Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218621 · ClinicalTrials.gov registry record
The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 20
- Enrollment target
NCT00218621: Completed study, sponsored by Johns Hopkins University.
NCT00218621 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218621 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of drugs used by treatment providers on the fetuses and infants of opiate dependent women. The subjects in this study are women enrolled in a large, multi-site, double blind study that looks at the effects of methadone and buprenorphine treatment during pregnancy. This study will evaluate fetal and maternal biophysiologic data longitudinally during pregnancy to determine how these substances may affect fetal neurobehavior. Additionally, infant neurobehavioral assessments and measurements of infant vagal tone will be collected to see how methadone and buprenorphine differentially affect the neonatal abstinence syndrome, or "withdrawal" in exposed neonates.
Interventions
- PROCEDURE Buprenorphine / methadone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218621
The ClinicalTrials.gov registry entry for NCT00218621 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine / methadone is the first listed.
NCT00218621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218621 about?
NCT00218621 is a clinical study titled "The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1". The purpose of this study is to evaluate the effects of drugs used by treatment providers on the fetuses and infants of opiate dependent women. The subjects in this study are women enrolled in a large, multi-site, double blind study that looks at the effects of methadone and buprenorphine treatment ...
What is the current status of trial NCT00218621?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2005-09. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00218621?
The interventions under investigation include: Buprenorphine / methadone (PROCEDURE).
Who is sponsoring clinical trial NCT00218621?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.